Evidence map›Paper›PMID 38233839›Full record

ArticleCell communication and signaling : CCS2024

NAT10 mediated ac4C acetylation driven m

Zhongting Mei, Zhihua Shen, Jiaying Pu, Qian Liu, Guoxin Liu, Xuting He, Yang Wang, Jinrui Yue, Shiyu Ge, Tao Li and 2 more

Open access · goldAbstract readVideo-Audio Media
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell communication and signaling : CCS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. The NAT10/acCell communication and signaling : CCS · 2026
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Zhongting Mei *Department of Pharmacology, (The State-Province Key Laboratories of Biomedicine Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Zhihua Shen *Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, China.
Jiaying Pu *Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, China.
Qian LiuDepartment of Pharmacology, (The State-Province Key Laboratories of Biomedicine Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Guoxin LiuDepartment of Pharmacology, (The State-Province Key Laboratories of Biomedicine Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Xuting HeDepartment of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, China.
Yang WangDepartment of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, China.
Jinrui YueDepartment of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, China.
Shiyu GeDepartment of Pharmacology, (The State-Province Key Laboratories of Biomedicine Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Tao LiDepartment of Pharmacology, (The State-Province Key Laboratories of Biomedicine Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Ye YuanDepartment of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, China. yuanye_hmu@126.com.
Lei YangDepartment of Orthopedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China. yangray83@vip.qq.com.
Harbin Medical University · CNSecond Affiliated Hospital of Harbin Medical University · CN

Funding

Outstanding Youth Project of Natural Science Fund of Heilongjiang Province YQ2020H019The First Affiliated Hospital of Harbin Medical University Excellent Young Talents Funding HYD2020JQ0013the National Natural Science Fund of China 82273026, 81972117
6 · The paper itself

Abstract

The dynamic changes of RNA N6-methyladenosine (m

Indexed as

OsteosarcomaPhosphofructokinasesAcetylationCytidineGlycolysisHumansLactate Dehydrogenase 5Nerve Tissue ProteinsN-Terminal AcetyltransferasesPhosphofructokinase-1, Muscle TypeRNARNA Splicing FactorsCytidineLactate Dehydrogenase 5N-acetylcytidineNAT10 protein, humanNerve Tissue ProteinsN-Terminal AcetyltransferasesPFKM protein, humanPhosphofructokinase-1, Muscle TypePhosphofructokinasesRNARNA Splicing FactorsYTHDC1 protein, humanac4C acetylationGlycolysisLDHAm6A methylationNAT10OsteosarcomaPFKMYTHDC1

Identifiers

PMID38233839
PMCPMC10795323
OpenAlexW4390938194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.